产品详情
简单介绍：
Anti-CYLD抗体产品质量稳定，实验效果明显，货期快，价格优惠，欢迎垂询订购！我公司长期供应**组化抗体、WB抗体、**组化试剂盒和抗体试验所需全部相关试剂、荧光标记抗体、单克隆抗体、多克隆抗体、各种标记的二抗IgG/IgM/IgD/IgA等科研实验抗体。Anti-CYLD抗体用于**组化实验,WB实验,相应的标记抗体有HRP标记抗体,FITC标记,BIO等。
详情介绍：
Rabbit Anti-CYLD
Cat. Number:
Anti-CYLD抗体KL-2756R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
Defects in CYLD are the
Anti-CYLD抗体cause of familial cylindromatosis (CYLD) also known as turban tumor syndrome or dermal eccrine cylindromatosis. CYLD is an autosomal dominant and highly tumor type-specific disorder. The tumors (known as cylindromas because of their characteristic microscopic architecture) are believed to arise from or recapitulate the appearance of the eccrine or apocrine cells of the skin that secrete sweat and scent respectively. Cylindromas arise predominantly in hairy parts of the body with approximately 90% on the head and neck. The development of a confluent mass which may ulcerate or become infected has led to the designation "turban tumor syndrome". The skin tumors show differentiation in the direction of hair structures, hence the synonym trichoepithelioma. CYLD has deubiquitinating activity.
Also known as:
CDMT; cylindromatosis
Anti-CYLD抗体(turban tumor syndrome); cylindromatosis 1; Deubiquitinating enzyme CYLD; EAC; HSPC057; KIAA0849; turban tumor syndrome; Ubiquitin thiolesterase CYLD; Ubiquitin-specific processing protease CYLD; CYLD_HUMAN; Ubiquitin carboxyl-terminal hydrolase CYLD; CYLD; BRSS; CDMT; CYLD1; CYLDI; EAC; MFT; MFT1; SBS; TEM; USPL2.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Chicken, Cow, Horse, .
●
Immunogen: KLH conjugated synthetic peptide derived from human cylindromatosis 1.
●
Predicted Molecular
Anti-CYLD抗体Weight: 105kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working dilutions Anti-CYLD抗体must be determined by the end user.
Not yet tested in other applications.
Optimal working dilutions Anti-CYLD抗体must be determined by the end user.
kl066Mu02 白介素1受体Ⅰ(IL1R1)多克隆抗体 Polyclonal Antibody to Interleukin 1 Receptor Type I (IL1R1)
kl068Mu02 神经胶质纤维酸性蛋白(GFAP)多克隆抗体 Polyclonal Antibody to Glial Fibrillary Acidic Protein (GFAP)
kl071Mu02 白介素1α(IL1α)多克隆抗体 Polyclonal Antibody to Interleukin 1 Alpha (IL1a)
kl072Bo01 防御素β2(DEFβ2)多克隆抗体 Polyclonal Antibody to Defensin Beta 2 (DEFb2)
kl072Mu02 防御素β2(DEFβ2)多克隆抗体 Polyclonal Antibody to Defensin Beta 2 (DEFb2)
kl073Mu02 白介素2(IL2)多克隆抗体 Polyclonal Antibody to Interleukin 2 (IL2)
kl074Mu02 **球蛋白G1(IgG1)多克隆抗体 Polyclonal Antibody to Immunoglobulin G1 (IgG1)
kl074Ra01 **球蛋白G1(IgG1)多克隆抗体 Polyclonal Antibody to Immunoglobulin G1 (IgG1)
kl076Mu02 白介素3(IL3)多克隆抗体 Polyclonal Antibody to Interleukin 3 (IL3)
kl077Gu01 白介素4(IL4)多克隆抗体 Polyclonal Antibody to Interleukin 4 (IL4)
kl077Mu02 白介素4(IL4)多克隆抗体 Polyclonal Antibody to Interleukin 4 (IL4)
kl077Ov01 白介素4(IL4)多克隆抗体 Polyclonal Antibody to Interleukin 4 (IL4)
kl077Si01 白介素4(IL4)多克隆抗体 Polyclonal Antibody to Interleukin 4 (IL4)
kl078Mu02 白介素5(IL5)多克隆抗体 Polyclonal Antibody to Interleukin 5 (IL5)
kl079Mu02 白介素6(IL6)多克隆抗体 Polyclonal Antibody to Interleukin 6 (IL6)
kl081Mu02 白介素9(IL9)多克隆抗体 Polyclonal Antibody to Interleukin 9 (IL9)
kl083Mu02 瘦素受体(LEPR)多克隆抗体 Polyclonal Antibody to Leptin Receptor (LEPR)
kl084Mu02 瘦素(LEP)多克隆抗体 Polyclonal Antibody to Leptin (LEP)
kl086Mu02 L选择素(SELL)多克隆抗体 Polyclonal Antibody to Selectin, Leukocyte (SELL)
kl087Mi02 单核细胞趋化蛋白1(MCP1)多克隆抗体 Polyclonal Antibody to Monocyte Chemotactic Protein 1 (MCP1)
kl089Mu02 单核细胞趋化蛋白3(MCP3)多克隆抗体 Polyclonal Antibody to Monocyte Chemotactic Protein 3 (MCP3)
